Timo Kylmälä

668 total citations
18 papers, 514 citations indexed

About

Timo Kylmälä is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Timo Kylmälä has authored 18 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Surgery. Recurrent topics in Timo Kylmälä's work include Prostate Cancer Treatment and Research (9 papers), Bone health and treatments (8 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Timo Kylmälä is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Bone health and treatments (8 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Timo Kylmälä collaborates with scholars based in Finland, Sweden and Denmark. Timo Kylmälä's co-authors include Teuvo L.J. Tammela, Inkeri Elomaa, Leila Risteli, Juha Risteli, T. Taube, M Kontturi, Hanna Tainio, O Alfthan, Mirja Ruutu and Jouko Viitanen and has published in prestigious journals such as British Journal of Cancer, European Journal of Cancer and The Prostate.

In The Last Decade

Timo Kylmälä

17 papers receiving 490 citations

Peers

Countries citing papers authored by Timo Kylmälä

Since Specialization

Citations

This map shows the geographic impact of Timo Kylmälä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Kylmälä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Kylmälä more than expected).

Fields of papers citing papers by Timo Kylmälä

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Kylmälä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Kylmälä. The network helps show where Timo Kylmälä may publish in the future.

Co-authorship network of co-authors of Timo Kylmälä

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Kylmälä. A scholar is included among the top collaborators of Timo Kylmälä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Kylmälä. Timo Kylmälä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Side-fenestrated catheter decreases leakage at the urethrovesical anastomosis after robot-assisted laparoscopic radical prostatectomy 2013 ·Scandinavian Journal of Urology ·Jarno Riikonen, Antti Kaipia, Mika Matikainen, Juha Koskimäki, Timo Kylmälä, Teuvo L.J. Tammela	7
2	Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer Updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years 2006 ·Scandinavian Journal of Urology and Nephrology ·Peter Iversen, Jan‐Erik Johansson, Pär Lodding, Timo Kylmälä, P.I. Lundmo, Peter Klarskov, Teuvo L.J. Tammela, İlker Taşdemir, Thomas Morris, J. Armstrong, (unknown)	28
3	Management of Prolonged Urinary Leakage at the Urethro-Vesical Anastomosis 2005 ·Urologia Internationalis ·Timo Kylmälä, Antti Kaipia, Mika Matikainen	4
4	Negative bacterial polymerase chain reaction (PCR) findings in prostate tissue from patients with symptoms of chronic pelvic pain syndrome (CPPS) and localized prostate cancer 2003 ·The Prostate ·(unknown), Kaisu Rantakokko‐Jalava, (unknown), Mikael Leppilahti, Timo Marttila, Timo Kylmälä, Teuvo L.J. Tammela	35
5	Treatment of Postoperative Male Urinary Incontinence Using Transurethral Macroplastique Injections 2003 ·Journal of Endourology ·Timo Kylmälä, Hanna Tainio, Mika Raitanen, Teuvo L.J. Tammela	24
6	Suspicious Urine Cytology (Class III) in Patients with Bladder Cancer: Should it be Considered as Negative or Positive? 2002 ·Scandinavian Journal of Urology and Nephrology ·Mika Raitanen, Risto Aine, Eevi Kaasinen, Tapani Liukkonen, Timo Kylmälä, Heini Huhtala, Teuvo L.J. Tammela	17
7	The dilemma of suspicious urine cytology in patients being followed for bladder cancer. 2001 ·PubMed ·Mika Raitanen, Risto Aine, Timo Kylmälä, Johanna Kallio, Tapani Liukkonen, Teuvo L.J. Tammela, (unknown)	4
8	Ulcer Perforation in Gastric Urinary Conduit: Never Use a Gastric Segment in the Urinary Tract if There Are Other Options Available 2000 ·Urologia Internationalis ·Hanna Tainio, Timo Kylmälä, Teuvo L.J. Tammela	2
9	Reduction of flutamide‐induced alanine aminotransferase elevation after replacement by bicalutamide in a patient with N+ disease treated with maximal androgen blockade as a primary treatment 1997 ·British Journal of Urology ·Christian Palmberg, Timo Kylmälä, Teuvo L.J. Tammela	2
10	Concomitant i.v. and oral clodronate in the relief of bone pain – a double-blind placebo-controlled study in patients with prostate cancer 1997 ·British Journal of Cancer ·Timo Kylmälä, T. Taube, (unknown), Leila Risteli, Juha Risteli, Inkeri Elomaa	72
11	Effect of Concomitant Administration of Clodronate and Estramustine Phosphate on their Bioavaibility in Patients with Metastasized Prostate Cancer 1996 ·Pharmacology & Toxicology ·Timo Kylmälä, (unknown), (unknown), Pauli Ylitalo, Teuvo L.J. Tammela	0
12	Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer 1995 ·British Journal of Cancer ·Timo Kylmälä, (unknown), Leila Risteli, Juha Risteli, M Kontturi, Inkeri Elomaa	80
13	The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study 1994 ·European Journal of Cancer ·T. Taube, Timo Kylmälä, Christel Lamberg‐Allardt, Teuvo L.J. Tammela, Inkeri Elomaa	33
14	The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer. 1994 ·PubMed ·Timo Kylmälä, Teuvo L.J. Tammela, T. Sam Lindholm, (unknown)	37
15	Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group 1993 ·European Journal of Cancer ·Timo Kylmälä, Teuvo L.J. Tammela, Leila Risteli, Juha Risteli, T. Taube, Inkeri Elomaa	59
16	Effect of oral clodronate on bone pain 1992 ·International Urology and Nephrology ·Inkeri Elomaa, Timo Kylmälä, Teuvo L.J. Tammela, Jouko Viitanen, (unknown), Mirja Ruutu, K. Jauhiainen, Martti Ala‐Opas, Leslíe L. Roos, (unknown), O Alfthan	94
17	Peptidergic Innervation of the Normal and Obstructed Human Pyeloureteral Junctions 1992 ·Urologia Internationalis ·Hanna Tainio, Timo Kylmälä, (unknown)	15
18	A controlled study with clodronate in patients with prostate cancer with emphasis to monitore bone metastases using type I collagen metabolites 1992 ·Bone and Mineral ·Timo Kylmälä, Teuvo L.J. Tammela, Leila Risteli, Juha Risteli, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact